<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-fentanyl.xml</id>
  <title>Recalls Watch: Fentanyl</title>
  <link rel="self" href="https://recalls.watch/feed/substance-fentanyl.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-09-16T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99837/</id>
    <title>OurPharma LLC: fentaNYL Citrate</title>
    <link href="https://recalls.watch/recall/fda/99837/"/>
    <updated>2026-09-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98694/</id>
    <title>Wells Pharma of Houston LLC: Phenylephrine Hydrochloride Injectable Solution and 6 more</title>
    <link href="https://recalls.watch/recall/fda/98694/"/>
    <updated>2026-05-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP deviations.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97779/</id>
    <title>STAQ Pharma, Inc.: Hydromorphone HCL PF and 2 more</title>
    <link href="https://recalls.watch/recall/fda/97779/"/>
    <updated>2025-10-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Incorrect or Missing Lot and/or Exp Date</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96222/</id>
    <title>Alvogen, Inc: Fentanyl Transdermal System CII</title>
    <link href="https://recalls.watch/recall/fda/96222/"/>
    <updated>2025-02-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-alvogen-issues-voluntary-nationwide-recall-one-lot-fentanyl-transdermal-system-2/</id>
    <title>Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System</title>
    <link href="https://recalls.watch/recall/fda/n-alvogen-issues-voluntary-nationwide-recall-one-lot-fentanyl-transdermal-system-2/"/>
    <updated>2025-01-31T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: There is potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93456/</id>
    <title>SCA Pharmaceuticals, LLC: Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection and 31 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93456"/>
    <updated>2024-04-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91788/</id>
    <title>Akorn, Inc.: Atropine Sulfate Ophthalmic Solution and 85 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91788"/>
    <updated>2023-06-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Firm went out of business and could no longer continue stability studies.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/92348/</id>
    <title>Apollo Care, LLC: PHENYLephrine HCl Injection and 15 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=92348"/>
    <updated>2023-05-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
</feed>
